Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer - Wikidata - wikimedia - TriplyDB

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

http://www.wikidata.org/entity/Q34565029

about

Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents Glycotherapy: new advances inspire a reemergence of glycans in medicine Retinoic acid and α-galactosylceramide regulate the expression of costimulatory receptors and transcription factors responsible for B cell activation and differentiation.Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients.Direct targeted glycation of the free sulfhydryl group of cysteine residue (Cys-34) of BSA. Mapping of the glycation sites of the anti-tumor Thomsen-Friedenreich neoglycoconjugate vaccine prepared by Michael addition reaction.Sweet beginning for cancer stem cells.Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells.Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity.Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes.Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients.Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation.Recent Developments in Synthetic Carbohydrate-Based Diagnostics, Vaccines, and Therapeutics.Carbohydrate-based vaccine adjuvants - discovery and development.Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.Synthesis of multivalent glycopeptide conjugates that mimic an HIV epitope.Affinity of monoclonal antibodies for Globo-series glycans Chemical Synthesis of the Tumor-Associated Globo H Antigen.Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity.Therapeutic Antibodies to Ganglioside GD2 Evolved from Highly Selective Germline Antibodies.Synthesis of Neisseria meningitidis serogroup W135 capsular oligosaccharides for immunogenicity comparison and vaccine development.The design and synthesis of an α-Gal trisaccharide epitope that provides a highly specific anti-Gal immune response.Immune activation with peptide assemblies carrying Lewis y tumor-associated carbohydrate antigen.Synthesis of conjugation-ready zwitterionic oligosaccharides by chemoselective thioglycoside activation

P2860

Q26771367-F418B0C4-E471-42F6-BB14-908F5E3B2A49 Q27027997-BF830248-3A77-450B-8C0A-19456AC3A7E5 Q33777284-E7A61395-8256-4474-A1EF-A90C62B09719 Q33778489-DE785A03-3633-46A0-B1A2-9D9FAE2D85A8 Q35492743-1C924449-3272-45B2-B467-71059934D2E5 Q36551575-902FBE43-993D-4977-AFB8-9AEC50948105 Q36551623-EDB45725-18AF-43E0-9219-75F062C84964 Q36931101-E81A0A1E-3BC9-413B-929B-CBF88DB00CDE Q37117835-614B0B67-5272-4E3A-A507-F60F0D0254C1 Q37420064-85622E50-7B45-4589-A9E4-7D7ACD39F078 Q37599805-C477A03D-11CE-48DA-B360-B786514D4747 Q37637068-AB241995-D1F3-4834-9FBA-081F30DE8C49 Q38497871-3DEBC522-8962-44BC-9ED9-055B95AE39BF Q38533442-E2FA97BA-87D8-4DFA-B465-20A0DAEEC22C Q38587300-75EC407F-7734-4E17-B3FA-621B4D17254C Q38778469-AD5EAEE1-1EE6-4485-9AA9-FC34CE9E545D Q39012279-2ECF1531-B6B8-47B0-BEC0-00E15F52991B Q41835711-CF31189C-2031-457D-A89C-42764CD43456 Q42149743-207409D8-5ABA-47D4-BE9B-325200B2A71E Q42424435-F55C05E5-1B41-430A-89CD-F3CD43C4F4C1 Q46226616-908C20FE-A0C5-4D02-86ED-0E9DE1BB6EB3 Q47945436-ED8B8A83-402A-40B9-B71B-ABBEA6BAE779 Q48030042-51B06C92-21DB-4016-8E35-D7376ADAC3AB Q48128075-B1CA8CF6-B6DF-4B3A-85F9-1926E67D0845 Q51141205-CA9A410E-7D43-4A49-91E5-4E53806BC78F Q57525962-3EAC3CC2-F649-416E-98FE-1CF6F7D86E61

P2860

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

http://www.wikidata.org/entity/Q34565029

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

@ast

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

@en

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

@nl

type

label

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

@ast

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

@en

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

@nl

prefLabel

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

@ast

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

@en

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

@nl

P1433

Q34565029-6D4C81B4-A0B3-443E-8FC3-1F7FF201DE1C

P1476

Q34565029-FB08A257-4AF4-4576-A09C-6F26A67CE608

P2093

Q34565029-2548723D-79B6-45F0-B032-2A53DF7CF53B

Q34565029-2E3D62D2-FDC5-4154-BAEC-0BC559F079EB

Q34565029-3096A1A5-3070-4FA6-BDE4-921D2ADFF8B1

Q34565029-332B87B0-CA61-46E5-88FA-A64D1A68517F

Q34565029-46E97D94-F3F9-46EB-8451-60722290DE11

Q34565029-47BC9065-65F8-40C8-AE0E-DD9EAD0FDCB0

Q34565029-4BAE1AB7-F465-4DED-8EC5-AB9C86883DE4

Q34565029-8DEB853C-DF38-466A-8AC4-0AC7F0F00A7F

Q34565029-A4846D6D-6799-4190-94AA-54C56586E1E7

Q34565029-EF460208-9238-4576-A5BF-A915330F2E3F

P2860

Q34565029-205FFB4D-7781-4EE2-B90E-3353D239E6E1

Q34565029-24A0F404-93C5-46C3-AA8E-A9BC7960136D

Q34565029-28D02496-70A2-40E0-B34F-8EE34645709C

Q34565029-2B343667-5BA6-421E-A769-0D9CEB4CCAD5

Q34565029-2C084E82-4AC5-4991-9AC5-5455223CCE0A

Q34565029-2E3EA387-9643-477C-9BB8-C142544EA48F

Q34565029-2F9B1141-44D0-42D8-A1F5-F44F8D4BC407

Q34565029-30FBD029-4A91-4104-9A78-C1D6D19EC541

Q34565029-3CABC24B-22C1-4C3D-AEF8-58BEF6A434A8

Q34565029-44E70511-59E7-4019-BE85-6123B71D472C

P304

Q34565029-953B74B7-FB80-4F8E-9A35-4A7FFBC6461E

P31

Q34565029-A54D3855-C728-4FE8-9828-CF11E5DD7DA2

P356

Q34565029-AEEF7994-3C1B-407B-A22E-CF8530000301

P407

Q34565029-906F3566-B4D2-49DB-8AF6-081FF5E6D75F

P433

Q34565029-73F3FB2F-5582-4138-A82F-35D8FF735309

P478

Q34565029-40BB5144-21D1-4900-85F6-04B80669C565

P50

Q34565029-A300B6F4-3422-4483-819F-B28A81A32538

Q34565029-DD85A620-0E71-48FC-8D95-7C5FC34375DB

P577

Q34565029-65290AD4-7772-49BD-990F-21C5091C4A2C

P5875

Q34565029-FBAED2DB-1189-46C6-9678-C6E660468E01

P698

Q34565029-04DFFBFE-1BFD-4BA0-BE53-7F5EB8E2B4EF

P932

Q34565029-C1183856-1A2A-4DE7-BDB9-3498B0DD5251

P356

PNAS.1222649110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

@en

P2093

Chi-Huey Wong

http://www.w3.org/2001/XMLSchema#string

Chien-Tai Ren

http://www.w3.org/2001/XMLSchema#string

Chung-Yi Wu

http://www.w3.org/2001/XMLSchema#string

Hsin-Yu Lee

http://www.w3.org/2001/XMLSchema#string

Jung-Tung Hung

http://www.w3.org/2001/XMLSchema#string

Kuo-Ching Chu

http://www.w3.org/2001/XMLSchema#string

Shiou-Ting Li

http://www.w3.org/2001/XMLSchema#string

Ting-Jen R Cheng

http://www.w3.org/2001/XMLSchema#string

Tsui-Ling Hsu

http://www.w3.org/2001/XMLSchema#string

Yen-Lin Huang

http://www.w3.org/2001/XMLSchema#string

P2860

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers

A new homobifunctional p-nitro phenyl ester coupling reagent for the preparation of neoglycoproteins.

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.

Effect of skin barrier disruption on immune responses to topically applied cross-reacting material, CRM(197), of diphtheria toxin.

Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen.

Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d

Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial

N-glycosylation of serum proteins in disease and its investigation using lectins.

P304

2517-2522

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1222649110

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Sarah K C Cheung

P577

2013-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235377358

http://www.w3.org/2001/XMLSchema#string

P698

23355685

http://www.w3.org/2001/XMLSchema#string

P932

3574961

http://www.w3.org/2001/XMLSchema#string